The Patent Finder

Terms ending in 2032

Respivert Limited

Every in-force patent on Respivert Limited's record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,108,9501-Pyrazolyl-3- (4- ((2 -Anilinopyrimidin- 4 - Yl) Oxy) Napththalen- 1- Yl) Ureas as P38 Map Kinase Inhibitors
In force
 · High confidence
Respivert LimitedIn forceHigh confidence
US 9,475,7961-Pyrazolyl-3-((4-((2-Anilinopyrimidin-4 -Yl) Oxy) NAPTHTHALEN-1 - Yl) Ureas as P38 Map Knase Inhibitors
In force
 · High confidence
Respivert LimitedIn forceHigh confidence
US 9,724,3471-Pyrazolyl-3-(4-((2-Anilinopyrimidin-4 -Yl) Oxy) NAPTHTHALEN-1 - Yl) Ureas as P38 Map Knase Inhibitors
In force
 · High confidence
Respivert Ltd.In forceHigh confidence
US 9,850,2311-Pyrazolyl-3- (4- ((2 -Anilinopyrimidin- 4 - Yl) Oxy) Napththalen- I - Yl) Ureas as P38 Mapkinase Inhibitors
In force
 · Low confidence
Respivert LimitedIn forceLow confidence
US 9,993,4781-Pyrazolyl-3-(4-((2-Anilinopyrimidin-4 -Yl) Oxy) NAPTHTHALEN-1 - Yl) Ureas as P38 Map Knase Inhibitors
In force
 · Medium confidence
Respivert Ltd.In forceMedium confidence
US 10,238,6581-Pyrazolyl-3-(4-((2-Anilinopyrimidin-4 -Yl) Oxy) NAPTHTHALEN-1 - Yl) Ureas as P38 Map Knase Inhibitors
In force
 · Medium confidence
Respivert LimitedIn forceMedium confidence
US 10,266,5191-Pyrazolyl-3- (4- ((2 -Anilinopyrimidin- 4 - Yl) Oxy) Napththalen- I - Yl) Ureas as P38 Mapkinase Inhibitors
In force
 · Low confidence
Respivert LimitedIn forceLow confidence
US 10,738,0321-Pyrazolyl-3- (4- ((2 -Anilinopyrimidin- 4 - Yl) Oxy) Napththalen- I - Yl) Ureas as P38 Mapkinase Inhibitors
In force
 · Low confidence
Respivert LimitedIn forceLow confidence
US 10,813,9321-Pyrazolyl-3-(4-((2-Anilinopyrimidin-4 -Yl) Oxy) NAPTHTHALEN-1 - Yl) Ureas as P38 Map Knase Inhibitors
In force
 · Medium confidence
Respivert LimitedIn forceMedium confidence
9 of 9 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited